日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer

DNA损伤反应特征与广泛期小细胞肺癌的一线化疗反应和肿瘤演变途径相关

Morris, Benjamin B; Heeke, Simon; Xi, Yuanxin; Diao, Lixia; Wang, Qi; Rocha, Pedro; Arriola, Edurne; Lee, Myung Chang; Tyson, Darren R; Concannon, Kyle; Ramkumar, Kavya; Stewart, C Allison; Cardnell, Robert J; Wang, Runsheng; Quaranta, Vito; Wang, Jing; Heymach, John V; Nabet, Barzin Y; Shames, David S; Gay, Carl M; Byers, Lauren A

Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations

非小细胞肺癌分子亚型及对免疫疗法联合治疗的敏感性

Lu, Tianshi; Hamidi, Habib; Socinski, Mark A; Reck, Martin; Cappuzzo, Federico; Barlesi, Fabrice; Jotte, Robert M; Müller, Sören; Qamra, Aditi; Amitai, Assaf; Guan, Xiangnan; Fuentes, Eloisa; Koeppen, Hartmut; Giltnane, Jennifer M; Shames, David S; Ballinger, Marcus; He, Meng Xiao; Wang, Yulei; Srivastava, Minu K; Nabet, Barzin Y

NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STING

NOTCH1通过重新激活STING逆转小细胞肺癌中的免疫抑制。

Kim, Yoo Sun; Nabet, Barzin Y; Cortez, Briana N; Sun, Nai-Yun; Sebastian, Robin; Redon, Christophe E; Ray, Anagh; Liu, Liang; Ishola, Afeez A; Loew, Sarah; Dhall, Anjali; Sindiri, Sivasish; Gayevskiy, Velimir; Lee, Min-Jung; Rastogi, Shraddha; Sato, Nahoko; Kedei, Noemi; Andresson, Thorkell; Das, Sudipto; Kumar, Suresh; Bers, Alan E; Zhang, Hongliang; Chiappori, Alberto; Gopal, Priyanka; Abazeed, Mohamed E; Chen, Haobin; Aladjem, Mirit I; Pommier, Yves; Velez, Moises J; Shames, David S; Roper, Nitin

Development and validation of a serum proteomic test for predicting patient outcomes in advanced non-small cell lung cancer treated with atezolizumab or docetaxel

开发和验证一种血清蛋白质组学检测方法,用于预测接受阿特珠单抗或多西他赛治疗的晚期非小细胞肺癌患者的预后。

Srivastava, Minu K; Zou, Wei; McCleland, Mark; Roder, Joanna; Asmellash, Senait; Norman, Patrick; Net, Lelia; Maguire, Laura; Roder, Heinrich; Georgantas, Robert; Shames, David S

Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

作者更正:新辅助阿特珠单抗治疗可切除非小细胞肺癌:一项开放标签、单臂 II 期试验

Chaft, Jamie E; Oezkan, Filiz; Kris, Mark G; Bunn, Paul A; Wistuba, Ignacio I; Kwiatkowski, David J; Owen, Dwight H; Tang, Yan; Johnson, Bruce E; Lee, Jay M; Lozanski, Gerard; Pietrzak, Maciej; Seweryn, Michal; Byun, Woo Yul; Schulze, Katja; Nicholas, Alan; Johnson, Ann; Grindheim, Jessica; Hilz, Stephanie; Shames, David S; Rivard, Chris; Toloza, Eric; Haura, Eric B; McNamee, Ciaran J; Patterson, G Alexander; Waqar, Saiama N; Rusch, Valerie W; Carbone, David P

Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T(reg) cells

出版商更正:抗TIGIT抗体通过髓系细胞和T(reg)细胞增强PD-L1阻断作用

Guan, Xiangnan; Hu, Ruozhen; Choi, Yoonha; Srivats, Shyam; Nabet, Barzin Y; Silva, John; McGinnis, Lisa; Hendricks, Robert; Nutsch, Katherine; Banta, Karl L; Duong, Ellen; Dunkle, Alexis; Chang, Patrick S; Han, Chia-Jung; Mittman, Stephanie; Molden, Nandini; Daggumati, Pallavi; Connolly, Wendy; Johnson, Melissa; Abreu, Delvys Rodriguez; Cho, Byoung Chul; Italiano, Antoine; Gil-Bazo, Ignacio; Felip, Enriqueta; Mellman, Ira; Mariathasan, Sanjeev; Shames, David S; Meng, Raymond; Chiang, Eugene Y; Johnston, Robert J; Patil, Namrata S

Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T(reg) cells

作者更正:抗TIGIT抗体通过髓系细胞和T(reg)细胞增强PD-L1阻断作用

Guan, Xiangnan; Hu, Ruozhen; Choi, Yoonha; Srivats, Shyam; Nabet, Barzin Y; Silva, John; McGinnis, Lisa; Hendricks, Robert; Nutsch, Katherine; Banta, Karl L; Duong, Ellen; Dunkle, Alexis; Chang, Patrick S; Han, Chia-Jung; Mittman, Stephanie; Molden, Nandini; Daggumati, Pallavi; Connolly, Wendy; Johnson, Melissa; Abreu, Delvys Rodriguez; Cho, Byoung Chul; Italiano, Antoine; Gil-Bazo, Ignacio; Felip, Enriqueta; Mellman, Ira; Mariathasan, Sanjeev; Shames, David S; Meng, Raymond; Chiang, Eugene Y; Johnston, Robert J; Patil, Namrata S

A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer

一种基于循环肿瘤DNA的纵向模型与转移性非小细胞肺癌的生存率相关

Assaf, Zoe June F; Zou, Wei; Fine, Alexander D; Socinski, Mark A; Young, Amanda; Lipson, Doron; Freidin, Jonathan F; Kennedy, Mark; Polisecki, Eliana; Nishio, Makoto; Fabrizio, David; Oxnard, Geoffrey R; Cummings, Craig; Rode, Anja; Reck, Martin; Patil, Namrata S; Lee, Mark; Shames, David S; Schulze, Katja

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer

循环肿瘤DNA监测在晚期非小细胞肺癌化疗-免疫治疗风险分层中的应用

Pellini, Bruna; Madison, Russell W; Childress, Merrida A; Miller, Shoshana T; Gjoerup, Ole; Cheng, Jason; Huang, Richard S P; Krainock, Michael; Gupta, Pratyush; Zou, Wei; Shames, David S; Moshkevich, Solomon; Ballinger, Marcus; Liu, Minetta C; Young, Amanda; Srivastava, Minu K; Oxnard, Geoffrey R; Socinski, Mark A

Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial

基于血液的肿瘤突变负荷作为阿特珠单抗治疗非小细胞肺癌的生物标志物:B-F1RST II期试验

Kim, Edward S; Velcheti, Vamsidhar; Mekhail, Tarek; Yun, Cindy; Shagan, Sarah M; Hu, Sylvia; Chae, Young Kwang; Leal, Ticiana A; Dowell, Jonathan E; Tsai, Michaela L; Dakhil, Christopher S R; Stella, Philip; Jin, Yanling; Shames, David S; Schleifman, Erica; Fabrizio, David A; Phan, See; Socinski, Mark A